Smart for Life
Smart for Life Q1 FY23: revenue $2.4M, down 46%; diluted EPS −$5.43
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0001213900-23-042008
Key figures from this report
These are the numbers Smart for Life reported for Q1 FY23, the quarter ended Mar 31, 2023, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.
- Revenue$2.4M−46% from $4.5M in Q1 FY2210-Q income statement, on EDGAR
- Net income−$4.3MAgainst −$16.6M in Q1 FY2210-Q income statement, on EDGAR
- Diluted EPS−$5.43Against −$0.82 in Q1 FY2210-Q income statement, on EDGAR
- Cash and cash equivalents$86K−94% from $1.6M in Q1 FY2210-Q balance sheet, on EDGAR
- Cash from operations−$379KAgainst −$4.2M in Q1 FY2210-Q cash flow statement, on EDGAR
Similar companies
Companies of similar size in SIC 2833 and related industry codes: the same peer list as the financial tables.
- Alterola Biotech ABTI
- Adia Nutrition ADIA public float $6M, Jun 30, 2025
- American Cannabis Company AMMJ
- Target Group CBDY public float $5M, Jun 30, 2025
- China Foods Holdings CFOO public float $864K, Jun 30, 2025
